 Radiotherapy, Adjuvant
"Radiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D018714
|
| MeSH Number(s) |
E02.186.775 E02.815.600
|
| Concept/Terms |
Radiotherapy, Adjuvant- Radiotherapy, Adjuvant
- Adjuvant Radiotherapy
- Adjuvant Radiotherapies
- Radiotherapies, Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, Adjuvant".
This graph shows the total number of publications written about "Radiotherapy, Adjuvant" by people in this website by year, and whether "Radiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 | | 1996 | 0 | 3 | 3 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 4 | 4 | | 2000 | 0 | 10 | 10 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 2 | 2 | | 2003 | 1 | 3 | 4 | | 2004 | 0 | 4 | 4 | | 2005 | 1 | 3 | 4 | | 2006 | 0 | 7 | 7 | | 2007 | 1 | 5 | 6 | | 2008 | 2 | 7 | 9 | | 2009 | 2 | 8 | 10 | | 2010 | 0 | 6 | 6 | | 2011 | 0 | 2 | 2 | | 2012 | 1 | 4 | 5 | | 2013 | 0 | 2 | 2 | | 2014 | 3 | 1 | 4 | | 2015 | 2 | 2 | 4 | | 2016 | 2 | 10 | 12 | | 2017 | 1 | 9 | 10 | | 2018 | 3 | 8 | 11 | | 2019 | 1 | 3 | 4 | | 2020 | 0 | 2 | 2 | | 2021 | 0 | 3 | 3 | | 2022 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Radiotherapy, Adjuvant" by people in Profiles.
-
Pisters K, Kris MG, Gaspar LE, Ismaila N. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2022 04 01; 40(10):1127-1129.
-
Merfeld EC, Burr AR, Brickson C, Neuman HB, Anderson BM. De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much? Clin Breast Cancer. 2022 06; 22(4):336-342.
-
Tsui DCC, Camidge DR, Rusthoven CG. Managing Central Nervous System Spread of Lung Cancer: The State of the Art. J Clin Oncol. 2022 02 20; 40(6):642-660.
-
Dominici L, Hu J, Zheng Y, Kim HJ, King TA, Ruddy KJ, Tamimi RM, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Wong JS, Partridge AH, Rosenberg SM. Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer. JAMA Surg. 2021 10 01; 156(10):e213758.
-
Zhou YW, Long YX, Song K, Liang LB, Cheng K, Chen Y, Liu JY. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas. Cancer Med. 2021 08; 10(16):5415-5428.
-
Aye JM, Xue W, Palmer JD, Walterhouse DO, Arnold MA, Heaton TE, Venkatramani R. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 04; 68(4):e28914.
-
Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 12; 72(6):2014-2028.
-
Weiss AR, Chen YL, Scharschmidt TJ, Chi YY, Tian J, Black JO, Davis JL, Fanburg-Smith JC, Zambrano E, Anderson J, Arens R, Binitie O, Choy E, Davis JW, Hayes-Jordan A, Kao SC, Kayton ML, Kessel S, Lim R, Meyer WH, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Schlapkohl M, Shulkin BL, Smith EA, Sorger JI, Terezakis S, Hawkins DS, Spunt SL, Wang D. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1110-1122.
-
Shinde A, Verma V, Jones BL, Li R, Glaser S, Freeman M, Melstrom L, Kang R, Parvathaneni U, Modi B, Amini A. The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma. Am J Clin Oncol. 2019 08; 42(8):636-642.
-
Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv. 2019 07 09; 3(13):2035-2039.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|